BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

Princeton: Bristol Myers Squibb has announced the appointment of Cari Gallman as Executive Vice President, General Counsel ...

Bristol Myers Squibb (BMS) plans to invest $40bn in the US over the next five years to bolster its research and manufacturing ...

The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

Cari Gallman is promoted to legal head role, replacing Sandra Leung who is retiring after 33 years at the company ...

Jeremy Walsh is now heading up artificial intelligence and information technology in a newly created position at the FDA.